作者
Manojit Mosur Swamynathan,Shan Kuang,Kaitlin Watrud,Mary R. Doherty,Charlotte Gineste,Grinu Mathew,Grace Q. Gong,Hilary Cox,E. H. C. Cheng,David J. Reiss,Jude Kendall,Diya Ghosh,Colleen R. Reczek,Xiang Zhao,Tali Herzka,Saulė Špokaitė,Antoine N. Dessus,Seung Tea Kim,Olaf Klingbeil,Juan Liu,Dawid G. Nowak,Habeeb Alsudani,Tse-Luen Wee,Youngkyu Park,Francesca Minicozzi,Keith Rivera,Ana S. Almeida,Kenneth Chang,Ram Prosad Chakrabarty,John E. Wilkinson,Phyllis A. Gimotty,Sarah D. Diermeier,Mikala Egeblad,Christopher R. Vakoc,Jason W. Locasale,Navdeep S. Chandel,Tobias Janowitz,James Hicks,Michael Wigler,Darryl Pappin,Roger Williams,Paolo Cifani,David A. Tuveson,Jocelyn Laporte,Lloyd C. Trotman
摘要
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34-the regulator of endosome identity and sorting-through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of